ArticleTransplantation and cellular therapy2024

Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy.

Aasha I Hoogland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.